Abiomed, Inc.
Abiomed, Inc. (ABMD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ABMD · as of Jun 9, 2026
Key Statistics
Explore Abiomed, Inc. Data
abmd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 44.4%
Competitors & Peers
abmd competitorsABMD
CKMTF
CSSPF
DGWPF
DWRKF
EKDHFStock Performance
Full HistoryAbout Abiomed, Inc.
Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while a…
what is abiomed, inc. · abmd stock overview · abiomed, inc. company profile · who is abiomed, inc. ceo · abmd NASDAQ · abiomed, inc. headquarters · abiomed, inc. business segments
About Stock Overview & Key Data
Abiomed, Inc. (ABMD) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 29, 1987. As of the latest trading session, ABMD stock price is $381.02, with a market capitalization of $17.2B. The stock has returned +31.19% over the past 12 months and +0.00% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Abiomed, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Abiomed, Inc. reported revenue of $1.0B and net income of $136.5M. For detailed data — including Abiomed, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Abiomed, Inc. (ABMD) stock price is $381.02. The stock is traded on NASDAQ under the ticker symbol ABMD. The 52-week range is $219.84 – $381.99.